GLP-1 Pills and the Ongoing Importance of Nutrition Support
As oral GLP-1 therapies expand, thoughtful nutrition support remains essential for safe, sustainable outcomes.
Motivational Interviewing and Brief Action Planning: Helping Patients Move from Intention to Action in Weight Management
Using Motivational Interviewing and Brief Action Planning to build commitment, improve adherence, and support long-term weight management.
Can GLP-1 Medications Help Patients with Non-Alcoholic Fatty Liver Disease?
GLP-1 medications have emerged as a possible pharmacological treatment for patients with non-alcoholic fatty liver disease.
What Do We Know About the Long-Term Use of GLP-1 Medications?
Though GLP-1s are generally considered to be safe, we are still learning about the safety of the long-term use of GLP-1 medications.
The Cancer Risk Reduction Potential of Weight Loss: What Health Care Providers Need to Know
There is growing evidence that suggests intentional weight loss mediated by lifestyle change or pharmacotherapies can reduce cancer risk in adults.
Can a GLP-1 Medication Help Treat Binge Eating?
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
Bridging the Competency Gap in Obesity Care: Elevating Behavior Change Counseling
While advancements such as GLP-1 medications and bariatric surgery have improved clinical outcomes, a persistent gap remains in the use of behavioral interventions for weight management.
Tirzepatide and Pregnancy: What Clinicians Need to Know
As with other GLP-1 medications, tirzepatide is currently not recommended for pregnant women or those planning to conceive.
Can Patients Safely Use GLP-1 Medications During Pregnancy?
Although semaglutide is generally considered to be safe, it is not recommended for women who are pregnant or trying to become pregnant.
Obesity Management in Primary Care: A Key Strategy for Type 2 Diabetes Control
Pharmacotherapy for Weight Loss and Type 2 Diabetes